【风口研报】医药板块成防御首选，α-干扰素、糖皮质激素等方向相关公司受重视

七印授权

51GHHAWKTQSNPXVNN82OO461PA96S6CBPC214FPW570LATJ0OT

2021-03-05 08:12:03

article

ED8B0D177E689ADD59C1678E3BF6A83A772B8AE4805E935D1C7D6F924CC5A3C6

zh-CN

FD7ECEC50DE0F3AFA4AC3BC710136BE57B828D65

9241663

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

e470c36fc6589a8696bfe2d34eb44da12efc0daf5bc2bf8adb36e1bd075756360683c8aad4f7748334c359bf1e5d0e99fe83ca0279194fc62498273e059291d81b

{"parameters":{"adaptation":"sa","commercial":"n"},"type":"cc"}

yuanben_6041e7d696b8d0.36259912

原本认证

https://www.yuanben.io/article/ceedd58c-7418-4e33-8d67-893eb418090c

{"author":"财联社","authorization_pub_key":"0233c6594f619ab2bc6f6d7b56a39f700c2fca37e71ae9483c5d5b750f22bc1bbc"}